Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO14474 | Klasea sogdiana | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO5241 | Myristica fragrans | Species | Myristicaceae | Eukaryota |
PMID[1955885] |
|||
NPO8263 | Asclepias vestita | Species | Apocynaceae | Eukaryota | UNPD* | |||
NPO28409 | Lens phaseoloides | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO16424 | Myristica cinnamomea | Species | Myristicaceae | Eukaryota | bark |
PMID[21910441] |
||
NPO5241 | Myristica fragrans | Species | Myristicaceae | Eukaryota | TCM_Taiwan* | |||
NPO2665 | Andinobates fulguritus | Species | Dendrobatidae | Eukaryota | UNPD* | |||
NPO8532 | Helipterum tenellum | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO5334 | Rhodotypos scandens | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO7237 | Xanthostemon oppositifolius | Species | Myrtaceae | Eukaryota | UNPD* | |||
NPO8303 | Catalpa bignonioides | Species | Bignoniaceae | Eukaryota | UNPD* | |||
NPO7393 | Esenbeckia nesiotica | Species | Rutaceae | Eukaryota | UNPD* | |||
NPO490 | Lophozonia menziesii | Species | Nothofagaceae | Eukaryota | UNPD* | |||
NPO5746 | Pancratium trianthum | Species | Amaryllidaceae | Eukaryota | UNPD* | |||
NPO19928 | Lachnoanaerobaculum saburreum | Species | Lachnospiraceae | Bacteria | UNPD* | |||
NPO17811 | Cephalonoplos segetum | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO6113 | Piper pedicellosum | Species | Piperaceae | Eukaryota | UNPD* | |||
NPO1382 | Hyptis tomentosa | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO29659 | Myristicae semen | NA | NA | NA | TCMSP* | |||
NPO5241 | Myristica fragrans | Species | Myristicaceae | Eukaryota | TM-MC* | |||
NPO5241 | Myristica fragrans | Species | Myristicaceae | Eukaryota | UNPD* | |||
NPO4539 | Ipomoea cristulata | Species | Convolvulaceae | Eukaryota | UNPD* | |||
NPO5162 | Comaster multifida | Species | Comatulidae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | MIC | = | 2 | ug/ml | 1955885 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 4 | ug/ml | 1955885 |
NPT3730 | Organism | Enterococcus durans | Enterococcus durans | MIC | = | 4 | ug/ml | 1955885 |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 8 | ug/ml | 1955885 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 8 | ug/ml | 1955885 |
NPT3730 | Organism | Enterococcus durans | Enterococcus durans | MIC | = | 8 | ug/ml | 1955885 |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 32 | ug/ml | 1955885 |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 76.2 | % | 20805034 | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 98.5 | % | 20805034 | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 93.1 | % | 20805034 | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 82 | % | 20805034 | |
NPT1881 | Uncleic Acid | Calf thymus DNA | Bos taurus | Activity | = | 24.4 | % | 20805034 |
NPT2 | Others | Unspecified | Activity | = | 42 | % | 20805034 | |
NPT2 | Others | Unspecified | Activity | = | 85 | % | 20805034 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 5260 | nM | 20805034 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 26 | % | 20805034 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 50 | % | 20805034 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 71 | % | 20805034 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 75.32 | % | 20805034 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 45.32 | % | 20805034 |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 1.25 | nM | 20805034 | |
NPT2 | Others | Unspecified | Inhibition | = | 69.4 | % | 21910441 | |
NPT2 | Others | Unspecified | Inhibition | = | 63 | % | 21910441 | |
NPT2 | Others | Unspecified | Inhibition | = | 44.9 | % | 21910441 | |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 2300 | nM | 21978676 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | IC50 | = | 2800 | nM | 27236720 |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | IC50 | = | 1940 | nM | 27236720 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 94.13 | % | 27236720 |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | Inhibition | = | 97.09 | % | 27236720 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.44 | 27236720 | ||
NPT2 | Others | Unspecified | Ratio IC50 | = | 0.69 | 27236720 | ||
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | Ki | = | 5860 | nM | 27236720 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Ki | = | 11460 | nM | 27236720 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC244441 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.968 | High Similarity | NPC233056 |
0.9535 | High Similarity | NPC264112 |
0.9535 | High Similarity | NPC194764 |
0.9535 | High Similarity | NPC65005 |
0.9528 | High Similarity | NPC135801 |
0.9524 | High Similarity | NPC26697 |
0.9462 | High Similarity | NPC290030 |
0.9449 | High Similarity | NPC469526 |
0.9449 | High Similarity | NPC34070 |
0.9318 | High Similarity | NPC472903 |
0.9268 | High Similarity | NPC196976 |
0.9179 | High Similarity | NPC472904 |
0.9134 | High Similarity | NPC107672 |
0.9098 | High Similarity | NPC175552 |
0.9055 | High Similarity | NPC8745 |
0.9048 | High Similarity | NPC13238 |
0.9024 | High Similarity | NPC195262 |
0.9024 | High Similarity | NPC188814 |
0.9023 | High Similarity | NPC170742 |
0.8992 | High Similarity | NPC92624 |
0.8976 | High Similarity | NPC10926 |
0.8963 | High Similarity | NPC203063 |
0.896 | High Similarity | NPC242895 |
0.8947 | High Similarity | NPC223836 |
0.8923 | High Similarity | NPC259942 |
0.8906 | High Similarity | NPC267846 |
0.8905 | High Similarity | NPC471417 |
0.8889 | High Similarity | NPC133909 |
0.8889 | High Similarity | NPC32032 |
0.8846 | High Similarity | NPC474998 |
0.8846 | High Similarity | NPC109123 |
0.8837 | High Similarity | NPC100067 |
0.8837 | High Similarity | NPC98254 |
0.8837 | High Similarity | NPC116513 |
0.8837 | High Similarity | NPC105157 |
0.8837 | High Similarity | NPC30501 |
0.8837 | High Similarity | NPC23126 |
0.8837 | High Similarity | NPC103356 |
0.8837 | High Similarity | NPC72158 |
0.8837 | High Similarity | NPC162612 |
0.8837 | High Similarity | NPC266689 |
0.8837 | High Similarity | NPC190043 |
0.8837 | High Similarity | NPC156539 |
0.8837 | High Similarity | NPC169250 |
0.8832 | High Similarity | NPC284556 |
0.8832 | High Similarity | NPC301178 |
0.881 | High Similarity | NPC73532 |
0.881 | High Similarity | NPC224273 |
0.881 | High Similarity | NPC156139 |
0.881 | High Similarity | NPC267552 |
0.881 | High Similarity | NPC143427 |
0.881 | High Similarity | NPC45438 |
0.881 | High Similarity | NPC115159 |
0.881 | High Similarity | NPC19174 |
0.8797 | High Similarity | NPC282780 |
0.8797 | High Similarity | NPC166480 |
0.8769 | High Similarity | NPC473017 |
0.8769 | High Similarity | NPC221777 |
0.8769 | High Similarity | NPC21305 |
0.8768 | High Similarity | NPC238629 |
0.8768 | High Similarity | NPC287722 |
0.8768 | High Similarity | NPC254659 |
0.876 | High Similarity | NPC62952 |
0.873 | High Similarity | NPC297186 |
0.873 | High Similarity | NPC248363 |
0.873 | High Similarity | NPC149246 |
0.871 | High Similarity | NPC121259 |
0.8705 | High Similarity | NPC142165 |
0.8705 | High Similarity | NPC38065 |
0.8705 | High Similarity | NPC242893 |
0.8682 | High Similarity | NPC477454 |
0.8662 | High Similarity | NPC38545 |
0.8662 | High Similarity | NPC171916 |
0.8651 | High Similarity | NPC159525 |
0.8647 | High Similarity | NPC175738 |
0.8633 | High Similarity | NPC119663 |
0.8629 | High Similarity | NPC299252 |
0.8629 | High Similarity | NPC61062 |
0.8629 | High Similarity | NPC277394 |
0.8615 | High Similarity | NPC473691 |
0.8601 | High Similarity | NPC3825 |
0.8601 | High Similarity | NPC85131 |
0.8601 | High Similarity | NPC472279 |
0.8601 | High Similarity | NPC88804 |
0.8594 | High Similarity | NPC91105 |
0.8594 | High Similarity | NPC86900 |
0.8593 | High Similarity | NPC72918 |
0.8592 | High Similarity | NPC80710 |
0.8592 | High Similarity | NPC166036 |
0.8592 | High Similarity | NPC203747 |
0.8592 | High Similarity | NPC203077 |
0.8592 | High Similarity | NPC238279 |
0.8592 | High Similarity | NPC254702 |
0.8592 | High Similarity | NPC3036 |
0.8592 | High Similarity | NPC139364 |
0.8592 | High Similarity | NPC194653 |
0.8583 | High Similarity | NPC146642 |
0.8582 | High Similarity | NPC139074 |
0.8582 | High Similarity | NPC40524 |
0.8582 | High Similarity | NPC213485 |
0.8582 | High Similarity | NPC88345 |
0.8571 | High Similarity | NPC279121 |
0.8571 | High Similarity | NPC207732 |
0.8571 | High Similarity | NPC105213 |
0.8571 | High Similarity | NPC475042 |
0.8571 | High Similarity | NPC158222 |
0.8561 | High Similarity | NPC291078 |
0.855 | High Similarity | NPC214620 |
0.8542 | High Similarity | NPC154345 |
0.8542 | High Similarity | NPC35 |
0.8542 | High Similarity | NPC256406 |
0.8542 | High Similarity | NPC227485 |
0.8538 | High Similarity | NPC475733 |
0.8531 | High Similarity | NPC102003 |
0.8531 | High Similarity | NPC195763 |
0.8531 | High Similarity | NPC264550 |
0.8531 | High Similarity | NPC105512 |
0.8531 | High Similarity | NPC264289 |
0.8531 | High Similarity | NPC333691 |
0.8531 | High Similarity | NPC69430 |
0.8531 | High Similarity | NPC40290 |
0.8531 | High Similarity | NPC142876 |
0.8531 | High Similarity | NPC200060 |
0.8531 | High Similarity | NPC139293 |
0.8531 | High Similarity | NPC92722 |
0.8529 | High Similarity | NPC118919 |
0.8529 | High Similarity | NPC191976 |
0.8527 | High Similarity | NPC472029 |
0.8527 | High Similarity | NPC65761 |
0.8521 | High Similarity | NPC108406 |
0.8521 | High Similarity | NPC95864 |
0.8521 | High Similarity | NPC188074 |
0.8521 | High Similarity | NPC125449 |
0.8519 | High Similarity | NPC44437 |
0.8516 | High Similarity | NPC215392 |
0.8511 | High Similarity | NPC70136 |
0.8511 | High Similarity | NPC157133 |
0.8507 | High Similarity | NPC186097 |
0.8507 | High Similarity | NPC475009 |
0.8507 | High Similarity | NPC475008 |
0.8504 | High Similarity | NPC294037 |
0.8504 | High Similarity | NPC34634 |
0.8504 | High Similarity | NPC265454 |
0.85 | High Similarity | NPC175013 |
0.8496 | Intermediate Similarity | NPC247477 |
0.8496 | Intermediate Similarity | NPC17840 |
0.8492 | Intermediate Similarity | NPC40649 |
0.8492 | Intermediate Similarity | NPC209486 |
0.8492 | Intermediate Similarity | NPC144343 |
0.8489 | Intermediate Similarity | NPC110419 |
0.8483 | Intermediate Similarity | NPC157784 |
0.8483 | Intermediate Similarity | NPC472912 |
0.8483 | Intermediate Similarity | NPC37684 |
0.8483 | Intermediate Similarity | NPC324233 |
0.8483 | Intermediate Similarity | NPC323626 |
0.8483 | Intermediate Similarity | NPC63187 |
0.8483 | Intermediate Similarity | NPC237994 |
0.8478 | Intermediate Similarity | NPC138099 |
0.8478 | Intermediate Similarity | NPC242994 |
0.8472 | Intermediate Similarity | NPC10467 |
0.8468 | Intermediate Similarity | NPC276111 |
0.8468 | Intermediate Similarity | NPC118288 |
0.8467 | Intermediate Similarity | NPC473391 |
0.8467 | Intermediate Similarity | NPC472364 |
0.8462 | Intermediate Similarity | NPC196277 |
0.8462 | Intermediate Similarity | NPC272721 |
0.8462 | Intermediate Similarity | NPC131451 |
0.8462 | Intermediate Similarity | NPC321011 |
0.8462 | Intermediate Similarity | NPC294852 |
0.8462 | Intermediate Similarity | NPC287395 |
0.8462 | Intermediate Similarity | NPC119059 |
0.8462 | Intermediate Similarity | NPC276930 |
0.8462 | Intermediate Similarity | NPC183655 |
0.8462 | Intermediate Similarity | NPC218490 |
0.8462 | Intermediate Similarity | NPC43669 |
0.8462 | Intermediate Similarity | NPC15329 |
0.8462 | Intermediate Similarity | NPC188679 |
0.8456 | Intermediate Similarity | NPC129752 |
0.8456 | Intermediate Similarity | NPC70859 |
0.8456 | Intermediate Similarity | NPC61153 |
0.8456 | Intermediate Similarity | NPC130899 |
0.8456 | Intermediate Similarity | NPC283590 |
0.8451 | Intermediate Similarity | NPC20791 |
0.8451 | Intermediate Similarity | NPC476535 |
0.8451 | Intermediate Similarity | NPC12377 |
0.8451 | Intermediate Similarity | NPC179271 |
0.845 | Intermediate Similarity | NPC309765 |
0.845 | Intermediate Similarity | NPC283514 |
0.8444 | Intermediate Similarity | NPC294226 |
0.8444 | Intermediate Similarity | NPC267205 |
0.844 | Intermediate Similarity | NPC59551 |
0.844 | Intermediate Similarity | NPC257025 |
0.8438 | Intermediate Similarity | NPC98305 |
0.8433 | Intermediate Similarity | NPC275504 |
0.8429 | Intermediate Similarity | NPC312256 |
0.8425 | Intermediate Similarity | NPC70433 |
0.8425 | Intermediate Similarity | NPC124714 |
0.8425 | Intermediate Similarity | NPC49402 |
0.8425 | Intermediate Similarity | NPC472905 |
0.8425 | Intermediate Similarity | NPC192083 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC244441 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9528 | High Similarity | NPD943 | Approved |
0.8667 | High Similarity | NPD651 | Clinical (unspecified phase) |
0.8571 | High Similarity | NPD1511 | Approved |
0.8451 | Intermediate Similarity | NPD1512 | Approved |
0.8425 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8356 | Intermediate Similarity | NPD1934 | Approved |
0.8299 | Intermediate Similarity | NPD2801 | Approved |
0.8261 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.8231 | Intermediate Similarity | NPD1201 | Approved |
0.8188 | Intermediate Similarity | NPD3882 | Suspended |
0.8168 | Intermediate Similarity | NPD9269 | Phase 2 |
0.8129 | Intermediate Similarity | NPD1510 | Phase 2 |
0.812 | Intermediate Similarity | NPD1470 | Approved |
0.8102 | Intermediate Similarity | NPD1240 | Approved |
0.8056 | Intermediate Similarity | NPD7390 | Discontinued |
0.7986 | Intermediate Similarity | NPD1607 | Approved |
0.7943 | Intermediate Similarity | NPD5404 | Approved |
0.7943 | Intermediate Similarity | NPD5406 | Approved |
0.7943 | Intermediate Similarity | NPD5405 | Approved |
0.7943 | Intermediate Similarity | NPD5408 | Approved |
0.7935 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7935 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7935 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7887 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7887 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7863 | Intermediate Similarity | NPD9268 | Approved |
0.7852 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7852 | Intermediate Similarity | NPD1164 | Approved |
0.7834 | Intermediate Similarity | NPD3818 | Discontinued |
0.7832 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7817 | Intermediate Similarity | NPD2935 | Discontinued |
0.7786 | Intermediate Similarity | NPD230 | Phase 1 |
0.7778 | Intermediate Similarity | NPD3022 | Approved |
0.7778 | Intermediate Similarity | NPD3021 | Approved |
0.7769 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7763 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7736 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7712 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7692 | Intermediate Similarity | NPD6232 | Discontinued |
0.7673 | Intermediate Similarity | NPD7054 | Approved |
0.7658 | Intermediate Similarity | NPD7473 | Discontinued |
0.7635 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7625 | Intermediate Similarity | NPD7472 | Approved |
0.7603 | Intermediate Similarity | NPD3750 | Approved |
0.7586 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7578 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7569 | Intermediate Similarity | NPD2796 | Approved |
0.7568 | Intermediate Similarity | NPD6799 | Approved |
0.7561 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7559 | Intermediate Similarity | NPD74 | Approved |
0.7559 | Intermediate Similarity | NPD9266 | Approved |
0.7554 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7548 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7548 | Intermediate Similarity | NPD7075 | Discontinued |
0.7531 | Intermediate Similarity | NPD7251 | Discontinued |
0.75 | Intermediate Similarity | NPD3027 | Phase 3 |
0.75 | Intermediate Similarity | NPD3300 | Phase 2 |
0.75 | Intermediate Similarity | NPD940 | Approved |
0.75 | Intermediate Similarity | NPD846 | Approved |
0.7485 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7482 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.748 | Intermediate Similarity | NPD9263 | Approved |
0.748 | Intermediate Similarity | NPD9267 | Approved |
0.748 | Intermediate Similarity | NPD9264 | Approved |
0.7468 | Intermediate Similarity | NPD7819 | Suspended |
0.7468 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7448 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7445 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7419 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD6599 | Discontinued |
0.7378 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7368 | Intermediate Similarity | NPD9493 | Approved |
0.7365 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7364 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7355 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7343 | Intermediate Similarity | NPD1613 | Approved |
0.7343 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7342 | Intermediate Similarity | NPD5494 | Approved |
0.7338 | Intermediate Similarity | NPD1203 | Approved |
0.7338 | Intermediate Similarity | NPD7411 | Suspended |
0.7315 | Intermediate Similarity | NPD6190 | Approved |
0.7308 | Intermediate Similarity | NPD5402 | Approved |
0.7303 | Intermediate Similarity | NPD5403 | Approved |
0.7303 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7292 | Intermediate Similarity | NPD447 | Suspended |
0.729 | Intermediate Similarity | NPD6801 | Discontinued |
0.7286 | Intermediate Similarity | NPD2798 | Approved |
0.7261 | Intermediate Similarity | NPD7768 | Phase 2 |
0.726 | Intermediate Similarity | NPD2799 | Discontinued |
0.726 | Intermediate Similarity | NPD3748 | Approved |
0.7256 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD6651 | Approved |
0.7218 | Intermediate Similarity | NPD9281 | Approved |
0.7215 | Intermediate Similarity | NPD3749 | Approved |
0.7212 | Intermediate Similarity | NPD6559 | Discontinued |
0.7209 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7206 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7205 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7203 | Intermediate Similarity | NPD3764 | Approved |
0.7188 | Intermediate Similarity | NPD6959 | Discontinued |
0.7181 | Intermediate Similarity | NPD2800 | Approved |
0.7171 | Intermediate Similarity | NPD2534 | Approved |
0.7171 | Intermediate Similarity | NPD2533 | Approved |
0.7171 | Intermediate Similarity | NPD5401 | Approved |
0.7171 | Intermediate Similarity | NPD2532 | Approved |
0.7165 | Intermediate Similarity | NPD9261 | Approved |
0.7162 | Intermediate Similarity | NPD2344 | Approved |
0.7153 | Intermediate Similarity | NPD3019 | Approved |
0.7153 | Intermediate Similarity | NPD2932 | Approved |
0.7134 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD8166 | Discontinued |
0.7113 | Intermediate Similarity | NPD9494 | Approved |
0.7097 | Intermediate Similarity | NPD2859 | Approved |
0.7097 | Intermediate Similarity | NPD2860 | Approved |
0.7083 | Intermediate Similarity | NPD2313 | Discontinued |
0.7083 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD919 | Approved |
0.7063 | Intermediate Similarity | NPD3020 | Approved |
0.7055 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7042 | Intermediate Similarity | NPD258 | Approved |
0.7042 | Intermediate Similarity | NPD257 | Approved |
0.703 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7027 | Intermediate Similarity | NPD3299 | Clinical (unspecified phase) |
0.7016 | Intermediate Similarity | NPD2933 | Approved |
0.7016 | Intermediate Similarity | NPD2934 | Approved |
0.7 | Intermediate Similarity | NPD9717 | Approved |
0.6993 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6987 | Remote Similarity | NPD3455 | Phase 2 |
0.698 | Remote Similarity | NPD6099 | Approved |
0.698 | Remote Similarity | NPD6100 | Approved |
0.698 | Remote Similarity | NPD9570 | Approved |
0.6975 | Remote Similarity | NPD1247 | Approved |
0.6974 | Remote Similarity | NPD2309 | Approved |
0.6957 | Remote Similarity | NPD6234 | Discontinued |
0.6954 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6954 | Remote Similarity | NPD1243 | Approved |
0.6944 | Remote Similarity | NPD6832 | Phase 2 |
0.6939 | Remote Similarity | NPD1933 | Approved |
0.6934 | Remote Similarity | NPD5536 | Phase 2 |
0.6933 | Remote Similarity | NPD7266 | Discontinued |
0.6933 | Remote Similarity | NPD2346 | Discontinued |
0.6929 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6908 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6908 | Remote Similarity | NPD4628 | Phase 3 |
0.6884 | Remote Similarity | NPD9545 | Approved |
0.6879 | Remote Similarity | NPD3226 | Approved |
0.6875 | Remote Similarity | NPD9569 | Approved |
0.6875 | Remote Similarity | NPD3018 | Phase 2 |
0.6871 | Remote Similarity | NPD825 | Approved |
0.6871 | Remote Similarity | NPD826 | Approved |
0.6855 | Remote Similarity | NPD37 | Approved |
0.6853 | Remote Similarity | NPD2797 | Approved |
0.6849 | Remote Similarity | NPD3268 | Approved |
0.6849 | Remote Similarity | NPD411 | Approved |
0.6846 | Remote Similarity | NPD1237 | Approved |
0.6845 | Remote Similarity | NPD5953 | Discontinued |
0.6842 | Remote Similarity | NPD2654 | Approved |
0.6828 | Remote Similarity | NPD4908 | Phase 1 |
0.6825 | Remote Similarity | NPD844 | Approved |
0.6824 | Remote Similarity | NPD1899 | Clinical (unspecified phase) |
0.6821 | Remote Similarity | NPD8397 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD643 | Clinical (unspecified phase) |
0.6809 | Remote Similarity | NPD1610 | Phase 2 |
0.6809 | Remote Similarity | NPD422 | Phase 1 |
0.6803 | Remote Similarity | NPD520 | Approved |
0.68 | Remote Similarity | NPD4308 | Phase 3 |
0.6797 | Remote Similarity | NPD3400 | Discontinued |
0.6791 | Remote Similarity | NPD9280 | Clinical (unspecified phase) |
0.6774 | Remote Similarity | NPD4357 | Discontinued |
0.6768 | Remote Similarity | NPD7199 | Phase 2 |
0.6765 | Remote Similarity | NPD4419 | Clinical (unspecified phase) |
0.6763 | Remote Similarity | NPD1548 | Phase 1 |
0.6761 | Remote Similarity | NPD3972 | Approved |
0.676 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6752 | Remote Similarity | NPD920 | Approved |
0.6741 | Remote Similarity | NPD228 | Approved |
0.6738 | Remote Similarity | NPD3023 | Approved |
0.6738 | Remote Similarity | NPD3026 | Approved |
0.6735 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6731 | Remote Similarity | NPD642 | Clinical (unspecified phase) |
0.6728 | Remote Similarity | NPD4966 | Approved |
0.6728 | Remote Similarity | NPD4965 | Approved |
0.6728 | Remote Similarity | NPD4967 | Phase 2 |
0.6726 | Remote Similarity | NPD7286 | Phase 2 |
0.6726 | Remote Similarity | NPD6020 | Phase 2 |
0.6714 | Remote Similarity | NPD3024 | Approved |
0.6714 | Remote Similarity | NPD3025 | Approved |
0.6713 | Remote Similarity | NPD2982 | Phase 2 |
0.6713 | Remote Similarity | NPD2983 | Phase 2 |
0.6711 | Remote Similarity | NPD275 | Approved |
0.6711 | Remote Similarity | NPD274 | Approved |
0.6709 | Remote Similarity | NPD1653 | Approved |
0.6691 | Remote Similarity | NPD9377 | Approved |
0.6691 | Remote Similarity | NPD9379 | Approved |
0.6689 | Remote Similarity | NPD259 | Phase 1 |
0.6687 | Remote Similarity | NPD7184 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD4625 | Phase 3 |
0.6667 | Remote Similarity | NPD9536 | Phase 1 |
PubChem CID   | 100313 |
ChEMBL   | CHEMBL524100 |
ZINC   |
Molecular Weight:   | 358.18 |
ALogP:   | -3.7358 |
MLogP:   | 3.22 |
XLogP:   | 5.61 |
# Rotatable Bonds:   | 14 |
Polar Surface Area:   | 97.99 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 4 |
# Rings:   | 2 |
# Heavy Atoms:   | 26 |